PMID: 6975943Nov 1, 1981Paper

Significance of Lyt phenotypes: Lyt2 antibodies block activities of T cells that recognize class 1 major histocompatibility complex antigens regardless of their function

Proceedings of the National Academy of Sciences of the United States of America
S L Swain

Abstract

The effect of anti-Lyt2 on the generation of helper T-cell function and on cytotoxic effects specific for subregions of the major histocompatibility complex (MHC) was determined. The addition of anti-Lyt2 without complement to in vitro cultures blocked the generation of allogeneic MHC-induced help and lymphokine production and cytotoxic effects when the response was directed against allogeneic class 1 MHC antigens (K and D gene products of the mouse H-2 complex) but had no effect when these responses were specific for class 2 MHC antigens (I region gene products). Anti-Lyt2 failed to block the response of help induced to allogeneic mixed lymphocyte-stimulating determinants or the production of lymphokines by T cells specific for class 1 MHC antigens when concanavalin A lectin was used to induce activity. These and earlier results indicate that the ability of anti-Lyt2 antisera to block function is correlated with T cell specificity for class 1 MHC antigens not with the functional activity of the cells.

References

Apr 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·E NakayamaL J Old
Sep 1, 1978·The Journal of Experimental Medicine·F H Bach, B J Alter
May 1, 1978·The Journal of Experimental Medicine·P J WettsteinJ A Frelinger
Jan 1, 1977·Cold Spring Harbor Symposia on Quantitative Biology·H Cantor, E A Boyse
Jan 1, 1979·Immunological Reviews·J A Ledbetter, L A Herzenberg
Sep 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·D H KatzB Benacerraf
Apr 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·S L SwainR W Dutton
Mar 1, 1981·The Journal of Experimental Medicine·D P DialynasF W Fitch
Sep 1, 1980·The Journal of Experimental Medicine·N HollanderI L Weissman
Feb 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·N HollanderI L Weissman
Jan 1, 1980·Immunological Reviews·K A Smith

❮ Previous
Next ❯

Citations

Jan 1, 1983·Immunogenetics·G KraalE C Butcher
Jan 1, 1988·Immunogenetics·H J YounP D Gottlieb
Jan 1, 1986·Immunogenetics·I D WalkerI F McKenzie
Jan 1, 1988·Immunogenetics·H DunckleyS W Serjeantson
Jan 1, 1988·Immunologic Research·H KiyonoJ R McGhee
Apr 1, 1991·Clinica Chimica Acta; International Journal of Clinical Chemistry·J J van Dongen, I L Wolvers-Tettero
Nov 1, 1985·Developmental Biology·E Rothenberg, J P Lugo
May 1, 1989·Mechanisms of Ageing and Development·B CinaderD N Sauder
Jan 1, 1983·Molecular Aspects of Medicine·N R FaridJ C Bear
Aug 1, 1991·Molecular Immunology·N AuphanA M Schmitt-Verhulst
Jan 1, 1996·Veterinary Immunology and Immunopathology·H YamamotoM Onuma
Jun 1, 1990·Immunology Letters·S Marusić-Galesić, K Pavelić
Mar 1, 1987·Human Immunology·H C Oettgen, C Terhorst
Jan 1, 1992·Comparative Biochemistry and Physiology. B, Comparative Biochemistry·H I NegmE L Cooper
Jan 1, 1996·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·H I NegmR S Abdel Halim
Apr 1, 1994·Current Opinion in Immunology·C B Davis, D R Littman
Feb 1, 1989·Immunology and Cell Biology·M T GillespieN J Deacon
Dec 1, 1989·Immunology and Cell Biology·M PanaccioN J Deacon
Apr 7, 1998·Nature Biotechnology·Z Nagy
Jul 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·S C MeuerE L Reinherz
Apr 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·A M KrenskyS J Burakoff
Oct 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·E T YehK L Rock
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·T OwensJ F Miller
Jan 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·W R WeissM F Good
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·Y SamstagT Staehelin
Dec 1, 1982·The Journal of Experimental Medicine·A N Barclay, D W Mason

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.